Sfoglia per Autore
VALIDATED MICROBIOLOGICAL ASSAY FOR JOSAMYCIN DETERMINATION IN ITS PHARMACEUTICAL FORMULATIONS
2020-01-01 Abdelghani Mahmoudi, Said Zerkout, Ann Van Schepdael, Med Selah Boukhechem, Hadjera Boujella, Laura-Mihaela Simon, Silvia De Francia, Elisa Pirro
The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients
2019-01-01 Allegra, Sarah; Cusato, Jessica; De Francia, Silvia; Longo, Filomena; Pirro, Elisa; Massano, Davide; Avataneo, Valeria; De Nicolò, Amedeo; Piga, Antonio; D'Avolio, Antonio
Pharmacogenetic of voriconazole antifungal agent in pediatric patients
2018-01-01 Allegra, Sarah; Fatiguso, Giovanna; Francia, Silvia De; Pirro, Elisa; Carcieri, Chiara; Cusato, Jessica; Nicolò, Amedeo De; Avataneo, Valeria; Perri, Giovanni Di; D'Avolio, Antonio
Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children
2018-01-01 Allegra, Sarah; Cusato, Jessica; De Francia, Silvia; Longo, Filomena; Pirro, Elisa; Massano, Davide; Piga, Antonio; D'Avolio, Antonio
Clinical relevance of deferasirox trough levels in β-thalassemia patients
2018-01-01 Allegra, Sarah; Massano, Davide; De Francia, Silvia; Longo, Filomena; Piccione, Francesca; Pirro, Elisa; Cusato, Jessica; D'Avolio, Antonio; Piga, Antonio
Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children
2018-01-01 Allegra, Sarah; Fatiguso, Giovanna; De Francia, Silvia; Favata, Fabio; Pirro, Elisa; Carcieri, Chiara; De Nicolò, Amedeo; Cusato, Jessica; Di Perri, Giovanni; D'Avolio, Antonio
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes
2018-01-01 Allegra, Sarah; Cusato, Jessica; DE FRANCIA, Silvia; Arduino, A; Longo, Filomena; Pirro, Elisa; Massano, Davide; DE NICOLO', Amedeo; Piga, Antonio Giulio; D'Avolio, Antonio
Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients
2018-01-01 Allegra, Sarah; Cusato, Jessica; De Francia, Silvia; Longo, Filomena; Pirro, Elisa; Massano, Davide; Avataneo, Valeria; De Nicolò, Amedeo; Piga, Antonio; D'Avolio, Antonio
Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection
2017-01-01 Allegra, Sarah; Fatiguso, Giovanna; De Francia, Silvia; Favata, Fabio; Pirro, Elisa; Carcieri, Chiara; De Nicolò, Amedeo; Cusato, Jessica; Di Perri, Giovanni; D'Avolio, Antonio
Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children
2017-01-01 Allegra, Sarah; Fatiguso, Giovanna; De Francia, Silvia; Favata, Fabio; Pirro, Elisa; Carcieri, Chiara; De Nicolò, Amedeo; Cusato, Jessica; Di Perri, Giovanni; D'Avolio, Antonio
Deferasirox pharmacokinetic evaluation in β-thalassaemia paediatric patients
2017-01-01 Allegra, Sarah; Cusato, Jessica; De Francia, Silvia; Pirro, Elisa; Massano, Davide; Piga, Antonio; D'Avolio, Antonio
Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma
2017-01-01 Cusato, Jessica; DE FRANCIA, Silvia; Allegra, Sarah; Carrella, Simona; Pirro, Elisa; Piccione, Francesca Maria; De Martino, Francesca; Ferrero, Anna; Daffara, Fulvia Claudia; Terzolo, Massimo; Berruti, Alfredo; DI CARLO, Francesco; Tampellini, Marco; D'Avolio, Antonio
Deferasirox pharmacokinetics evaluation in a woman with hereditary haemochromatosis and heterozygous β-thalassaemia
2016-01-01 Allegra, Sarah; De Francia, Silvia; Longo, Filomena; Massano, Davide; Cusato, Jessica; Arduino, Arianna; Pirro, Elisa; Piga, Antonio; D'Avolio, Antonio
Bioequivalence of Branded and Generic Oxaliplatin: From Preclinical Assessment to Clinical Incidence of Hypersensitivity Reactions
2016-01-01 Tampellini, Marco; Benedetto, Simone; Rubatto, Elena; Baratelli, Chiara; DI Scipio, Federica; Pirro, Elisa; Brizzi, Maria Pia; Sonetto, Cristina; DI Maio, Massimo; Berta, Giovanni Nicolao; Scagliotti, Giorgio Vittorio
Preclinical pharmacokinetics comparison between resveratrol 2-hydroxypropyl-β-cyclodextrin complex and resveratrol suspension after oral administration
2016-01-01 Yang, Zhiqian; Argenziano, Monica; Salamone, Paolina; Pirro, Elisa; Sprio, Andrea E.; Di Scipio, Federica; Carere, Maria E.; Quaglino, Elena; Cavallo, Federica; Cavalli, Roberta; Berta, Giovanni N.
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes
2016-01-01 Sarah Allegra, Silvia De Francia, Jessica Cusato, Arianna Arduino, Elisa Pirro, Davide Massano, Filomena Longo, Antonio Piga, Antonio D'Avolio.
Deferasirox pharmacokinetic and toxicity correlation in β-thalassaemia major treatment
2016-01-01 Allegra, Sarah; De Francia, Silvia; Cusato, Jessica; Pirro, Elisa; Massano, Davide; Piga, Antonio; D'Avolio, Antonio
Plasma and Intracellular Imatinib Concentrations in Patients With Chronic Myeloid Leukemia
2014-01-01 De Francia S; Dʼavolio A; Ariaudo A; Pirro E; Piccione F; Simiele M; Fava C; Calcagno A; Di Perri G; Saglio G.
Influence of single nucleotide polymorphisms on deferasirox Ctrough levels and effectiveness: study on beta-talassemia major affected patients
2014-01-01 De Francia S; Allegra S; D'Avolio A; Cusato J; Massano D; Pirro E; Racca S; Poli G
Single nucleotide polymorphisms of ABCB1 gene influence on intracellular concentrations of dasatinib.
2013-01-01 E. Pirro; S. De Francia; A. D'Avolio; A. Ariaudo; M. Simiele; J. Cusato; C. Fava; L. Baietto; G. Di Perri; G. Saglio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| VALIDATED MICROBIOLOGICAL ASSAY FOR JOSAMYCIN DETERMINATION IN ITS PHARMACEUTICAL FORMULATIONS | 2020 | Abdelghani Mahmoudi, Said Zerkout, Ann Van Schepdael, Med Selah Boukhechem, Hadjera Boujella, Laura-Mihaela Simon, Silvia De Francia, Elisa Pirro | |
| The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients | 2019 | Allegra, Sarah; Cusato, Jessica; De Francia, Silvia; Longo, Filomena; Pirro, Elisa; Massano, Davide; Avataneo, Valeria; De Nicolò, Amedeo; Piga, Antonio; D'Avolio, Antonio | |
| Pharmacogenetic of voriconazole antifungal agent in pediatric patients | 2018 | Allegra, Sarah; Fatiguso, Giovanna; Francia, Silvia De; Pirro, Elisa; Carcieri, Chiara; Cusato, Jessica; Nicolò, Amedeo De; Avataneo, Valeria; Perri, Giovanni Di; D'Avolio, Antonio | |
| Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children | 2018 | Allegra, Sarah; Cusato, Jessica; De Francia, Silvia; Longo, Filomena; Pirro, Elisa; Massano, Davide; Piga, Antonio; D'Avolio, Antonio | |
| Clinical relevance of deferasirox trough levels in β-thalassemia patients | 2018 | Allegra, Sarah; Massano, Davide; De Francia, Silvia; Longo, Filomena; Piccione, Francesca; Pirro, Elisa; Cusato, Jessica; D'Avolio, Antonio; Piga, Antonio | |
| Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children | 2018 | Allegra, Sarah; Fatiguso, Giovanna; De Francia, Silvia; Favata, Fabio; Pirro, Elisa; Carcieri, Chiara; De Nicolò, Amedeo; Cusato, Jessica; Di Perri, Giovanni; D'Avolio, Antonio | |
| Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes | 2018 | Allegra, Sarah; Cusato, Jessica; DE FRANCIA, Silvia; Arduino, A; Longo, Filomena; Pirro, Elisa; Massano, Davide; DE NICOLO', Amedeo; Piga, Antonio Giulio; D'Avolio, Antonio | |
| Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients | 2018 | Allegra, Sarah; Cusato, Jessica; De Francia, Silvia; Longo, Filomena; Pirro, Elisa; Massano, Davide; Avataneo, Valeria; De Nicolò, Amedeo; Piga, Antonio; D'Avolio, Antonio | |
| Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection | 2017 | Allegra, Sarah; Fatiguso, Giovanna; De Francia, Silvia; Favata, Fabio; Pirro, Elisa; Carcieri, Chiara; De Nicolò, Amedeo; Cusato, Jessica; Di Perri, Giovanni; D'Avolio, Antonio | |
| Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children | 2017 | Allegra, Sarah; Fatiguso, Giovanna; De Francia, Silvia; Favata, Fabio; Pirro, Elisa; Carcieri, Chiara; De Nicolò, Amedeo; Cusato, Jessica; Di Perri, Giovanni; D'Avolio, Antonio | |
| Deferasirox pharmacokinetic evaluation in β-thalassaemia paediatric patients | 2017 | Allegra, Sarah; Cusato, Jessica; De Francia, Silvia; Pirro, Elisa; Massano, Davide; Piga, Antonio; D'Avolio, Antonio | |
| Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma | 2017 | Cusato, Jessica; DE FRANCIA, Silvia; Allegra, Sarah; Carrella, Simona; Pirro, Elisa; Piccione, Francesca Maria; De Martino, Francesca; Ferrero, Anna; Daffara, Fulvia Claudia; Terzolo, Massimo; Berruti, Alfredo; DI CARLO, Francesco; Tampellini, Marco; D'Avolio, Antonio | |
| Deferasirox pharmacokinetics evaluation in a woman with hereditary haemochromatosis and heterozygous β-thalassaemia | 2016 | Allegra, Sarah; De Francia, Silvia; Longo, Filomena; Massano, Davide; Cusato, Jessica; Arduino, Arianna; Pirro, Elisa; Piga, Antonio; D'Avolio, Antonio | |
| Bioequivalence of Branded and Generic Oxaliplatin: From Preclinical Assessment to Clinical Incidence of Hypersensitivity Reactions | 2016 | Tampellini, Marco; Benedetto, Simone; Rubatto, Elena; Baratelli, Chiara; DI Scipio, Federica; Pirro, Elisa; Brizzi, Maria Pia; Sonetto, Cristina; DI Maio, Massimo; Berta, Giovanni Nicolao; Scagliotti, Giorgio Vittorio | |
| Preclinical pharmacokinetics comparison between resveratrol 2-hydroxypropyl-β-cyclodextrin complex and resveratrol suspension after oral administration | 2016 | Yang, Zhiqian; Argenziano, Monica; Salamone, Paolina; Pirro, Elisa; Sprio, Andrea E.; Di Scipio, Federica; Carere, Maria E.; Quaglino, Elena; Cavallo, Federica; Cavalli, Roberta; Berta, Giovanni N. | |
| Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes | 2016 | Sarah Allegra, Silvia De Francia, Jessica Cusato, Arianna Arduino, Elisa Pirro, Davide Massano, Filomena Longo, Antonio Piga, Antonio D'Avolio. | |
| Deferasirox pharmacokinetic and toxicity correlation in β-thalassaemia major treatment | 2016 | Allegra, Sarah; De Francia, Silvia; Cusato, Jessica; Pirro, Elisa; Massano, Davide; Piga, Antonio; D'Avolio, Antonio | |
| Plasma and Intracellular Imatinib Concentrations in Patients With Chronic Myeloid Leukemia | 2014 | De Francia S; Dʼavolio A; Ariaudo A; Pirro E; Piccione F; Simiele M; Fava C; Calcagno A; Di Perri G; Saglio G. | |
| Influence of single nucleotide polymorphisms on deferasirox Ctrough levels and effectiveness: study on beta-talassemia major affected patients | 2014 | De Francia S; Allegra S; D'Avolio A; Cusato J; Massano D; Pirro E; Racca S; Poli G | |
| Single nucleotide polymorphisms of ABCB1 gene influence on intracellular concentrations of dasatinib. | 2013 | E. Pirro; S. De Francia; A. D'Avolio; A. Ariaudo; M. Simiele; J. Cusato; C. Fava; L. Baietto; G. Di Perri; G. Saglio |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile